Cited by 917Pancreatic function and diabetesDiabetes Treatment and ManagementDiabetes Management and Research

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*

Open access

Perley, Michael J., Kipnis, David M.·1967·Journal of Clinical Investigation

Open this paper in CoChat — free account Open PDF

Abstract

The plasma insulin responses of normal weight and obese, diabetic, and nondiabetic subjects to intravenous glucose was only 30-40% of that seen after oral glucose, indicating that alimentary mechanism(s) in addition to the arterial blood sugar concentration regulate insulin secretion. Observations made in subjects with diverted portal circulation indicate that the alimentary insulinogenic mechanism is located in the intestinal tract. The insulinogenic potency of the alimentary and glycemic stimuli expressed in terms of insulin secretion per gram of glucose were remarkably similar within each group of individuals. Between these groups, however, there were considerable differences. Obesity, with or without associated diabetes, was associated with a true hypersecretory responsiveness, whereas diabetes was characterized, with or without obesity, by a marked impairment in insulin secretion. The experimental design used in these studies permitted quantitation of the magnitude of the glycemic component of an oral glucose load. As a consequence of impaired insulin secretion, a greater than normal proportion of the oral glucose load escapes initial hepatic extraction in the maturity-onset diabetic and enters the peripheral circulation. Therefore, in the noninsulin-requiring maturity-onset diabetic, the glycemic insulinogenic stimulus for a given oral glucose load is significantly greater than in normal subjects and accounts for the excessive plasma insulin responses observed late in the course of an oral glucose tolerance test.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci105685

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

DETERMINATION OF BLOOD SUGAR
Somogyi, M. (1945) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43098-0 · Cited by 1,788
Plasma Insulin Response to Oral and Intravenous Glucose Administration1
ELRICK, H., STIMMLER, L., HLAD, C. J., & ARAI, Y. (1964) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-24-10-1076 · Cited by 857
Insulin Secretion in Response to Glycemic Stimulus: Relation of Delayed Initial Release to Carbohydrate intolerance in Mild Diabetes Mellitus*
Seltzer, H. S., Allen, E. W., Herron, A. L., & Brennan, M. T. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105534 · Cited by 819 · cited 1×
“(24) and Cerasi and Luft (25) that insulin secretion is impaired in diabetes mellitus.”
Background
New Interpretation of Oral Glucose Tolerance
Mcintyre, N., Holdsworth, C. D., & Turner, D. S. (1964) · The Lancet · doi:10.1016/s0140-6736(64)90011-x · Cited by 738
Promotion of Insulin Secretion by Glucagon
Samols, E., Marri, G., & Marks, V. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90761-0 · Cited by 521
Intestinal Factors in the Control of Insulin Secretion
McIntyre, N., Holdsworth, C. D., & Turner, D. S. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1317 · Cited by 382
THE PLASMA INSULIN RESPONSE TO GLUCOSE INFUSION IN HEALTHY SUBJECTS AND IN DIABETES MELLITUS
Cerasi, E., & Luft, R. (1967) · Acta Endocrinologica · doi:10.1530/acta.0.0550278 · Cited by 371
Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects
Perley, M., & Kipnis, D. M. (1966) · Diabetes · doi:10.2337/diab.15.12.867 · Cited by 330
Self-citation
Plasma Insulin Concentrations in Nondiabetic and Early Diabetic Subjects: Determinations by a New Sensitive Immuno-assay Technic
Yalow, R. S., & Berson, S. A. (1960) · Diabetes · doi:10.2337/diab.9.4.254 · Cited by 330
PLASMA INSULIN AND GROWTH HORMONE LEVELS IN OBESITY AND DIABETES
Yalow, R. S., Glick, S. M., Roth, J., & Berson, S. A. (1965) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb34803.x · Cited by 199

Show all 24 references

Sorted by citations

Items 201–300 of 914

An Integrated Glucose‐Insulin Model to Describe Oral Glucose Tolerance Test Data in Type 2 Diabetics
Jauslin, P. M., Silber, H. E., Frey, N., Gieschke, R., Simonsson, U. S. H., Jorga, K. M., & Karlsson, M. O. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007302168 · Cited by 80
Effects of ethanol ingestion on glucose tolerance and insulin secretion in normal and diabetic subjects
McMonagle, J. R., & Felig, P. (1975) · Metabolism · doi:10.1016/0026-0495(75)90142-0 · Cited by 78
Gastric inhibitory polypeptide (GIP) and insulin release after small-bowel resection in man
Lauritsen, K. B., Moody, A. J., Christensen, K. C., & Lindkár Jensen, S. (1980) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528009181538 · Cited by 77
Inflammation of the Hypothalamus Leads to Defective Pancreatic Islet Function
Calegari, V. C., Torsoni, A. S., Vanzela, E. C., ARAUJO, E. P. D., Morari, J., Zoppi, C. C., Sbragia, L., Boschero, A. C., & Velloso, L. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.173021 · Cited by 77
Retracted
New insights into the role of cAMP in the production and function of the incretin hormone glucagon-like peptide-1 (GLP-1)
Yu, Z., & Jin, T. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.09.032 · Cited by 72
MECHANISMS IN ENDOCRINOLOGY: Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion
Sonne, D. P., Hansen, M., & Knop, F. K. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0154 · Cited by 75
The Role of Carbohydrates in Appetite, Hunger and Obesity
Geiselman, P. J., & Novin, D. (1982) · Appetite · doi:10.1016/s0195-6663(82)80017-2 · Cited by 77
Chemical Senses in the Release of Gastric and Pancreatic Secretions
Brand, J. G., Cagan, R. H., & Naim, M. (1982) · Annual Review of Nutrition · doi:10.1146/annurev.nu.02.070182.001341 · Cited by 75
Insulin Secretion in Diabetes Mellitus
KIPNIS, D. M. (1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-5-891 · Cited by 76
Self-citation
The significance and interpretation of mildly abnormal oral glucose tolerance
ALFORD, F. P., Martin, P. I. R., & Pearson, M. J. (1971) · Diabetologia · doi:10.1007/bf01212550 · Cited by 75
Effect of various oral glucose doses on plasma neutral amino acid levels
Pan, R. C. M.-D., Mauron, C., Glaeser, B. S., & Wurtman, R. J. (1982) · Metabolism · doi:10.1016/0026-0495(82)90185-8 · Cited by 74
Incretin hormones - an update
Holst, J. J., & Ørskov, C. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/clb.61.234.75.85 · Cited by 77
Glucokinase and candidate genes for Type 2 (non-insulin-dependent) diabetes mellitus
Randle, P. J. (1993) · Diabetologia · doi:10.1007/bf00400227 · Cited by 74
Metabolic hormones are integral regulators of female reproductive health and function
Athar, F., Karmani, M., & Templeman, N. M. (2023) · Bioscience Reports · doi:10.1042/bsr20231916 · Cited by 82
Glucagon-Like-Peptide-1 Secretion from Canine L-Cells Is Increased by Glucose-Dependent-Insulinotropic Peptide but Unaffected by Glucose
Damholt, A. B., Buchan, A. M. J., & Kofod, H. (1998) · Endocrinology · doi:10.1210/endo.139.4.5921 · Cited by 72
Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes: Past, present, and future
Adetunji, O., Kalra, S., Baruah, M., Sahay, R. K., Unnikrishnan, A., & Uppal, S. (2016) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.176351 · Cited by 74
The incretins: a link between nutrients and well-being
Burcelin, R. (2005) · British Journal Of Nutrition · doi:10.1079/bjn20041340 · Cited by 71
The incretins: From the concept to their use in the treatment of type 2 diabetes. Part A: Incretins: Concept and physiological functions
Girard, J. R. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.09.001 · Cited by 75
Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes
Jensen, D. H., Aaboe, K., Henriksen, J. E., Vølund, A., Holst, J. J., Madsbad, S., & Krarup, T. (2012) · Diabetologia · doi:10.1007/s00125-012-2459-7 · Cited by 70
Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
Bifari, F., Manfrini, R., Dei, M., Berra, C., Siano, M., Zuin, M. G., Paroni, R. C., & Folli, F. B. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.09.025 · Cited by 71
Pancreatic alpha and beta cell functions in cystic fibrosis
Lippe, B. M., Sperling, M. A., & Dooley, R. R. (1977) · The Journal of Pediatrics · doi:10.1016/s0022-3476(77)81241-9 · Cited by 69
Bench-to-bedside review: The gut as an endocrine organ in the critically ill
Deane, A. M., Chapman, M. J., Fraser, R. J., & Horowitz, M. (2010) · Critical Care · doi:10.1186/cc9039 · Cited by 65
Enteral nutritional therapy.
Rombeau, J., & Barot, L. R. (1981) · Surgical Clinics of North America · doi:10.1016/s0039-6109(16)42441-2 · Cited by 69
Obesity: A Serious Symptom
Bray, G. A., DAVIDSON, M. B., & DRENICK, E. J. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-77-5-779 · Cited by 66
Glucagon-like Peptide-1 Receptor Agonists: A Class Update for Treating Type 2 Diabetes
Lovshin, J. A. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.08.242 · Cited by 67
Mechanism of Postgastrectomy Hypoglycemia
Shultz, K. T. (1971) · Archives of Internal Medicine · doi:10.1001/archinte.128.2.240 · Cited by 66
Glucagon-like peptide-1(7–37)/(7–36)amide is a new incretin
Fehmann, H. C., Göke, R., & Göke, B. (1992) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(92)90118-p · Cited by 65
A Link between Insulin Resistance and Hyperinsulinemia: Inhibitors of Phosphatidylinositol 3-Kinase Augment Glucose-Induced Insulin Secretion from Islets of Lean, But Not Obese, Rats
Zawalich, W. S., & Zawalich, K. C. (2000) · Endocrinology · doi:10.1210/endo.141.9.7636 · Cited by 70
Recent advances in understanding the role of glucagon-like peptide 1
Reed, J., Bain, S., & Kanamarlapudi, V. (2020) · F1000Research · doi:10.12688/f1000research.20602.1 · Cited by 66
The Mechanism of insulin secretion after oral glucose administration
Fischer, U., Hommel, H., Ziegler, M., & Michael, R. (1972) · Diabetologia · doi:10.1007/bf01235634 · Cited by 65
Diabetic cardiomyopathy: signaling defects and therapeutic approaches
Dobrin, J. S., & Lebeche, D. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.17 · Cited by 63
Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways
Nishizawa, M., Nakabayashi, H., Uehara, K., Nakagawa, A., Uchida, K., & Koya, D. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00565.2012 · Cited by 66
Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits
Shiomi, M., Ito, T., Tsukada, T., Tsujita, Y., & Horikoshi, H. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00259-7 · Cited by 63
Role of dipeptidyl peptidase 4 inhibitors in the new era of antidiabetic treatment
Florentin, M., Kostapanos, M. S., & Papazafiropoulou, A. K. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i2.85 · Cited by 68
Blood insulin responses to blood glucose levels in high output sepsis and septic shock
Gh, C., Martin, H., Walji, S., Hirsch, E. F., Gazitua, R., & Goodfellow, R. M. (1978) · The American Journal of Surgery · doi:10.1016/0002-9610(78)90040-5 · Cited by 63
The Acute Effect of Fat on Insulin Secretion
Collier, G., Greenberg, G. R., Wolever, T. M. S., & Jenkins, D. J. A. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-2-323 · Cited by 61
The gastrointestinal stimulus to insulin release
Kraegen, E. W., Chisholm, D. J., Young, J. D., & Lazarus, L. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106262 · Cited by 61
The effect of hyperglycemia, hyperinsulinemia, and route of glucose administration on glucose oxidation and glucose storage
Jacot, E., DeFronzo, R. A., Jéquier, E., Maeder, E., & Jp, F. (1982) · Metabolism · doi:10.1016/0026-0495(82)90183-4 · Cited by 61
Cholesterol in β-cell Dysfunction: The Emerging Connection Between HDL Cholesterol and Type 2 Diabetes
Brunham, L. R., Kruit, J. K., Hayden, M. R., & Verchere, C. B. (2010) · Current Diabetes Reports · doi:10.1007/s11892-009-0090-x · Cited by 63
Dipeptidyl peptidase iv inhibitors and diabetes therapy
McIntosh, C. H. S. (2007) · Frontiers in bioscience · doi:10.2741/2797 · Cited by 59
Insulin secretory response of diabetics during the period of improvement of glucose tolerance to normal range
Kosáka, K., Hagura, R., Kuzuya, T., & Kuzuya, N. (1974) · Diabetologia · doi:10.1007/bf01219540 · Cited by 60
Suppressive effect of secretin upon pancreatic alpha cell function
Santeusanio, F., Faloona, G. R., & Unger, R. H. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106975 · Cited by 60
Incretin‐based therapies
Stonehouse, A. H., Darsow, T., & Maggs, D. G. (2011) · Journal of Diabetes · doi:10.1111/j.1753-0407.2011.00143.x · Cited by 65
Exenatide and weight loss
Bradley, D. P., Kulstad, R., & Schoeller, D. A. (2010) · Nutrition · doi:10.1016/j.nut.2009.07.008 · Cited by 62
New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders
Irwin, N. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i15.1285 · Cited by 61
Mechanisms and clinical efficacy of lixisenatide for the management of type 2 diabetes
Horowitz, M., Rayner, C. K., & Jones, K. L. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0009-4 · Cited by 58
Non-Insulin Antidiabetic Therapy in Cardiac Patients: Current Problems and Future Prospects
Fisman, E. Z., Motro, M., & Tenenbaum, A. (2008) · Advances in cardiology · doi:10.1159/000115193 · Cited by 58
Dietary Effects on Incretin Hormone Secretion
Wu, T., Rayner, C. K., Jones, K. L., & Horowitz, M. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00003-5 · Cited by 58
Effects of chronic administration of alogliptin on the development of diabetes and β ‐cell function in high fat diet/streptozotocin diabetic mice
Zhang, X., Wang, Z., Huang, Y. Q., & Wang, J. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01354.x · Cited by 57
A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies
Barnett, A. H., Allsworth, J., Jameson, K., & Mann, R. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x199691 · Cited by 57
Exploiting the antidiabetic properties of incretins to treat type 2 diabetes mellitus: glucagon-like peptide 1 receptor agonists or insulin for patients with inadequate glycemic control?
Gaal, L. F. V., Gutkin, S. W., & Nauck, M. A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0804 · Cited by 58
Glucose Stimulates Pulsatile Insulin Secretion from Human Pancreatic Islets by Increasing Secretory Burst Mass: Dose-Response Relationships
Ritzel, R. A., Veldhuis, J. D., & Butler, P. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021250 · Cited by 56
Pancreatic and Extrapancreatic Effects of Gastric Inhibitory Polypeptide
Yamada, Y., Miyawaki, K., Tsukiyama, K., Harada, N., Yamada, C., & Seino, Y. (2006) · Diabetes · doi:10.2337/db06-s011 · Cited by 55
Cirrhosis and diabetes
Conn, H. O., Schreiber, W., Elkington, S. G., & Johnson, T. R. (1969) · Digestive Diseases and Sciences · doi:10.1007/bf02233205 · Cited by 56
Bariatric surgery and obesity: influence on the incretins
Laferrère, B. (2016) · International Journal of Obesity Supplements · doi:10.1038/ijosup.2016.8 · Cited by 55
Factor analysis of the metabolic syndrome in spinal cord-injured men
Jones, L. M., Legge, M., & Goulding, A. (2004) · Metabolism · doi:10.1016/j.metabol.2004.04.013 · Cited by 54
Hepatic and extrahepatic splanchnic glucose metabolism in the postabsorptive and glucose fed dog
Barrett, E. J., Ferrannini, E., Gusberg, R., Bevilacqua, S., & DeFronzo, R. A. (1985) · Metabolism · doi:10.1016/0026-0495(85)90205-7 · Cited by 55
Cholinergic Modification of Glucose-Induced Biphasic Insulin Release in Vitro
Sharp, R. A., Culbert, S. J., Cook, J., Jennings, A. S., & Burr, I. M. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107609 · Cited by 54
Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and β-cell mass to age-related insulin resistance in rats
Matveyenko, A. V., Veldhuis, J. D., & Butler, P. C. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90451.2008 · Cited by 54
The relative contribution of the nervous system, hormones, and metabolites to the total insulin response during a meal in the rat
Berthoud, H. R. (1984) · Metabolism · doi:10.1016/0026-0495(84)90157-4 · Cited by 52
Physiology of the Incretin Hormones, GIP and GLP ‐1—Regulation of Release and Posttranslational Modifications
Holst, J. J., Albrechtsen, N. J. W., ROSENKILDE, M. M., & Deacon, C. F. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180013 · Cited by 72
Small Intestinal Glucose Exposure Determines the Magnitude of the Incretin Effect in Health and Type 2 Diabetes
Marathe, C. S., Rayner, C. K., Bound, M. J., Checklin, H. L., Standfield, S., Wishart, J. M., Lange, K. M., Jones, K. L., & Horowitz, M. (2014) · Diabetes · doi:10.2337/db13-1757 · Cited by 54
Effects of coffee ingestion on oral glucose tolerance curves in normal human subjects
Feinberg, L. J., Sandberg, H., Castro, O. D., & Bellet, S. (1968) · Metabolism · doi:10.1016/0026-0495(68)90158-3 · Cited by 53
A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease
Fisman, E. Z., & Tenenbaum, A. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-38 · Cited by 52
Effect of Gastrointestinal Hormones on Insulin and Glucagon Secretion
Creutzfeldt, W., Feurle, G. E., & Ketterer, H. (1970) · New England Journal of Medicine · doi:10.1056/nejm197005142822006 · Cited by 52
Oral glucose tolerance test: Effect of different glucose loads on splanchnic carbohydrate and substrate metabolism in healthy man
Bratusch-Marrain, P. R., Waldhäusl, W. K., Gasic, S., Korn, A., & Nowotny, P. (1980) · Metabolism · doi:10.1016/0026-0495(80)90071-2 · Cited by 52
Effect of a Purified Amylase Inhibitor on Carbohydrate Tolerance in Normal Subjects and Patients With Diabetes Mellitus
Layer, P., Rizza, R. A., Zinsmeister, A. R., Carlson, G. L., & DiMagno, E. P. (1986) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61978-8 · Cited by 51
Clinical aspects of islet B‐cell function in non‐insulin‐dependent diabetes mellitus
Ward, W. K., Beard, J. C., & Porte, D. (1986) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610020305 · Cited by 51
The mechanism of insulin secretion after oral glucose administration
Hommel, H., & Fischer, U. (1977) · Diabetologia · doi:10.1007/bf01219711 · Cited by 50
α‐Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon‐like peptide 1 (7–36 amide) and to delay gastric emptying in Type 2 diabetic patients
Hücking, K., Kostic, Z., Pox, C., Ritzel, R., Holst, J. J., Schmiegel, W., & Nauck, M. A. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01451.x · Cited by 57
INSULIN RATHER THAN GLUCOSE HOM$OElig;OSTASIS IN THE PATHOPHYSIOLOGY OF DIABETES
TURNER, R. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91739-6 · Cited by 51
Efficacy and safety of liraglutide compared to sulphonylurea during R amadan in patients with type 2 diabetes ( LIRA‐R amadan): a randomized trial
Azar, S. T., Echtay, A. S., Bebakar, W. M. W., araj, S., BERRAH, A., Omar, M. A. K., Mutha, A., Tornøe, K., Kaltoft, M. S., & Shehadeh, N. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12733 · Cited by 50
New treatments in type 2 diabetes: a focus on the incretin‐based therapies
Barnett, A. H. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03396.x · Cited by 50
Gastrointestinal Hormones and Insulin Secretion
Rehfeld, J. F. (1972) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365527209180744 · Cited by 49
Time Course of the Starve-refeed Response in Rats; the Possible Role of Insulin
Szepesi, B., & Berdanier, C. D. (1971) · Journal of Nutrition · doi:10.1093/jn/101.11.1563 · Cited by 49
Secretory effects of secretin on isolated perfused porcine pancreas.
Jensen, S. L., Fahrenkrug, J., Holst, J. J., Kuhl, C. K., Nielsen, O. V., & de Muckadell, O. B. S. (1978) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1978.235.4.e381 · Cited by 49
Detailed characterization of incretin cell distribution along the human small intestine
Guedes, T. P., Martins, S., Costa, M. M., Pereira, S. S., Morais, T., Santos, A., Nora, M. C., & Monteiro, M. P. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.02.011 · Cited by 46
Role of the incretin system in the remission of type 2 diabetes following bariatric surgery
Mingrone, G. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.07.004 · Cited by 48
The use of exenatide in severely burned pediatric patients
Mecott, G. A., Herndon, D. N., Kulp, G. A., Brooks, N. C., Al-Mousawi, A. M., Kraft, R., Rivero, H. G., Williams, F. N., Branski, L. K., & Jeschke, M. G. (2010) · Critical Care · doi:10.1186/cc9222 · Cited by 48
Bariatric surgery and its impact on sleep architecture, sleep-disordered breathing, and metabolism
Pannain, S., & Mokhlesi, B. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.07.007 · Cited by 48
A role for the gut-to-brain GLP-1-dependent axis in the control of metabolism
Burcelin, R., Sérino, M., & Cabou, C. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.09.003 · Cited by 47
Measurement of pulsatile insulin secretion in the rat: direct sampling from the hepatic portal vein
Matveyenko, A. V., Veldhuis, J. D., & Butler, P. C. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90335.2008 · Cited by 47
Familial partial lipodystrophy: Complications of obesity in the non-obese?
Robbins, D. C., Horton, E. S., Tulp, O. L., & Sims, E. A. H. (1982) · Metabolism · doi:10.1016/0026-0495(82)90232-3 · Cited by 46
Glucagon‐like peptide ‐1 receptor agonist ‐based agents and weight loss composition: Filling the gaps
Dubin, R. L., Heymsfield, S. B., Ravussin, E., & Greenway, F. L. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15913 · Cited by 47
Recent Advances in Antidiabetic Drug Therapies Targeting the Enteroinsular Axis
Flatt, P. R., Bailey, C. J., & Green, B. (2009) · Current Drug Metabolism · doi:10.2174/138920009787522124 · Cited by 46
Abnormalities of insulin pulsatility and glucose oscillations during meals in obese noninsulin-dependent diabetic patients: effects of weight reduction
Gumbiner, B., Cauter, E. V., Beltz, W. F., Ditzler, T. M., Griver, K., Polonsky, K. S., & Henry, R. R. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.6.8964829 · Cited by 46
Gastro-intestinal hormones GIP and GLP-1
Kieffer, T. J. (2004) · Annales d Endocrinologie · doi:10.1016/s0003-4266(04)95625-9 · Cited by 46
Intestinal effects of α‐glucosidase inhibitors: absorption of nutrients and enterohormonal changes
Göke, B., Herrmann, C. H., Göke, R., Fehmann, H. C., Berghöfer, P., Richter, G., & Arnold, R. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb02252.x · Cited by 46
Normal Growth with Subnormal Growth-Hormone Levels
Holmes, L. B., FRANTZ, A. G., Rabkin, M. T., Soeldner, J. S., & Crawford, J. D. (1968) · New England Journal of Medicine · doi:10.1056/nejm196809122791101 · Cited by 46
AN INTEGRATED VIEW OF β-CELL DYSFUNCTION IN TYPE-II DIABETES
Poitout, D., & Robertson, M. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.69 · Cited by 62
Short-Term Outcomes of Laparoscopic Single Anastomosis Gastric Bypass (LSAGB) for the Treatment of Type 2 Diabetes in Lower BMI (<30 kg/m2) Patients
Kim, M., & Hur, K. Y. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1202-5 · Cited by 45
Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose
Zhang, Y., Han, C., Zhu, W., Yang, G., Peng, X., Mehta, S., Zhang, J., Chen, L., & Liu, Y. (2021) · Cells · doi:10.3390/cells10092495 · Cited by 47
Incretin Mimetics and Dipeptidyl Peptidase-IV Inhibitors: A Review of Emerging Therapies for Type 2 Diabetes
Kendall, D. M., Kim, D. S., & Maggs, D. G. (2006) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.8.385 · Cited by 44
Age and the Endocrine System
Noth, R. H., & Mazzaferri, E. L. (1985) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30966-2 · Cited by 45
The Role of Insulin Resistance in the Pathogenesis of Diabetes Mellitus
Reaven, G. M., & Olefsky, J. M. (1978) · Advances in metabolic disorders · doi:10.1016/b978-0-12-027309-6.50021-5 · Cited by 44
The 75-g oral glucose tolerance test: Effect on splanchnic metabolism of substrates and pancreatic hormone release in healthy man
Waldhäusl, W. K., Gasic, S., Bratusch-Marrain, P. R., & Nowotny, P. (1983) · Diabetologia · doi:10.1007/bf00284457 · Cited by 45
Glucose, insulin, and growth hormone studies in long-term users of oral contraceptives
Spellacy, W. N., Buhi, W. C., SPELLACY, C. E., Moses, L. E., & Goldzieher, J. W. (1970) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(70)90259-0 · Cited by 45
Antidiabetic Agents: Past, Present and Future
Mehanna, A. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.13 · Cited by 43
The regulation of gastric ghrelin secretion
Nunez‐Salces, M., Li, H., Feinle‐Bisset, C., Young, R. L., & Page, A. J. (2020) · Acta Physiologica · doi:10.1111/apha.13588 · Cited by 48
Effect of secretin on basal- and glucose-stimulated insulin secretion in man
Fahrenkrug, J., de Muckadell, O. B. S., & Kuhl, C. K. (1978) · Diabetologia · doi:10.1007/bf01219421 · Cited by 44

Authors: Perley, M. J., & Kipnis, D. M.
Affiliations: Washington University in St. Louis (US)
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 1967-12-01
Volume: 46
Issue: 12
Pages: 1954-1962
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci105685
PMC: PMC292948
OpenAlex: W2169558934
Cited by: 917
References: 24
Citations by year: 2026: 12 · 2025: 12 · 2024: 15 · 2023: 17 · 2022: 12 · 2021: 16 · 2020: 20 · 2019: 25 · 2018: 15 · 2017: 15 · 2016: 28 · 2015: 33 · 2014: 13 · 2013: 25 · 2012: 16
FWCI: 60.63
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords: insulin secretion, oral glucose tolerance, intravenous glucose, obesity, type 2 diabetes, hypersecretion, insulin resistance
MeSH terms: Adolescent, Adult, Aged, Arteries, Capillaries, Child, Diabetes Mellitus, Glucose, Humans, Infusions, Parenteral, Insulin, Middle Aged, Obesity, Veins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks